NASDAQ:ABIO ARCA biopharma (ABIO) Stock Price, News & Analysis → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free ABIO Stock Alerts $3.28 +0.08 (+2.50%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$3.20▼$3.3350-Day Range$1.71▼$4.0052-Week Range$1.56▼$4.49Volume13,535 shsAverage Volume832,611 shsMarket Capitalization$47.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get ARCA biopharma alerts: Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. About ARCA biopharma Stock (NASDAQ:ABIO)ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.Read More ABIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABIO Stock News HeadlinesJune 4, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with OrukaMay 14, 2024 | investorplace.com3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty RallyMay 10, 2024 | businesswire.comARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIOMay 1, 2024 | msn.comNoah Gragson Expands 2024 Schedule with NASCAR Xfinity and ARCA RacesApril 30, 2024 | msn.comNoah Gragson adds NASCAR Xfinity, ARCA races to 2024 scheduleApril 28, 2024 | msn.comConnor Zilisch wins ARCA Menards Series race at Dover, first of his careerApril 27, 2024 | msn.comConnor Zilisch reacts to winning first ARCA race as NASCAR career takes next stepApril 27, 2024 | msn.comRed Flags at Dover as Scary Head-On Crash Leaves Amber Balcaen Limping After Attempt to Avoid ARCA Star's Flaming FiascoApril 25, 2024 | investorplace.comABIO Stock Earnings: ARCA biopharma Reported Results for Q1 2024April 25, 2024 | globenewswire.comARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateApril 20, 2024 | money.usnews.comARCA biopharma IncApril 20, 2024 | msn.com18-year-old Jake Finch leads every lap to capture ARCA victory at TalladegaApril 9, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIOApril 5, 2024 | businesswire.comARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIOApril 3, 2024 | investorplace.comWhy Is ARCA Biopharma (ABIO) Stock Up 85% Today?April 3, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with OrukaApril 3, 2024 | marketwatch.comARCA Biopharma in Reverse Merger Pact With Oruka TherapeuticsApril 3, 2024 | msn.comFibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare moversApril 3, 2024 | bizjournals.comNew Paragon spinout lands $275M financing — and reverse mergerApril 3, 2024 | markets.businessinsider.comARCA Biopharma, Oruka Therapeutics To Combine In All-stock Deal - Quick FactsApril 3, 2024 | msn.comSmall-Cap ARCA Biopharma Stock Soars On Merger Pact: The DetailsApril 3, 2024 | businesswire.comABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to ShareholdersApril 3, 2024 | globenewswire.comARCA biopharma and Oruka Therapeutics Announce Merger AgreementApril 3, 2024 | globenewswire.comARCA biopharma and Oruka Therapeutics Announce Merger AgreementMarch 27, 2024 | msn.comARCA Sensation Toni Breidinger Divulges Struggles of ‘Imposter’ Feeling in Male-Dominated NASCARSee More Headlines Receive ABIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/25/2024Today6/11/2024Next Earnings (Estimated)7/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:ABIO CUSIPN/A CIK907654 Webarcabio.com Phone(720) 940-2100Fax720-208-9261Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-16.08% Return on Assets-15.51% Debt Debt-to-Equity RatioN/A Current Ratio23.19 Quick Ratio23.19 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.89 per share Price / Book1.13Miscellaneous Outstanding Shares14,510,000Free Float10,024,000Market Cap$47.59 million OptionableOptionable Beta0.97 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Thomas A. Keuer (Age 65)President, COO & Principal Executive Officer Comp: $400.8kMr. C. Jeffrey Dekker CPA (Age 59)CFO, Treasurer & Company Secretary Comp: $323.07kKey CompetitorsAchieve Life SciencesNASDAQ:ACHVAlpha TeknovaNASDAQ:TKNOVolitionRxNYSE:VNRXImmuCellNASDAQ:ICCCAspira Women's HealthNASDAQ:AWHView All Competitors ABIO Stock Analysis - Frequently Asked Questions How have ABIO shares performed in 2024? ARCA biopharma's stock was trading at $1.70 at the beginning of the year. Since then, ABIO shares have increased by 92.9% and is now trading at $3.28. View the best growth stocks for 2024 here. When is ARCA biopharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, July 19th 2024. View our ABIO earnings forecast. How were ARCA biopharma's earnings last quarter? ARCA biopharma, Inc. (NASDAQ:ABIO) posted its earnings results on Thursday, April, 25th. The biopharmaceutical company reported ($0.14) earnings per share for the quarter. What is Michael R. Bristow's approval rating as ARCA biopharma's CEO? 1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of ARCA biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP). Who are ARCA biopharma's major shareholders? ARCA biopharma's stock is owned by a variety of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Christopher David Ozeroff and Fund Lp Funicular. View institutional ownership trends. How do I buy shares of ARCA biopharma? Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ABIO) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARCA biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.